# Provectus Biopharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Jul 22, 2026

- Company: [Provectus Biopharmaceuticals, Inc.](/companies/pvct.md) (CIK 315545)
- Form: SCHEDULE 13D/A
- Filed: 2026-07-22
- Accepted by EDGAR: Jul 22, 2026, 15:04 ET
- Period: not reported
- Accession: 0001493152-26-034217
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/315545/000149315226034217/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/315545/000149315226034217/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/315545/000149315226034217/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jul 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-034217. Last ingested by Listed: Oct 30, 2026, 11:33 ET. No prices; not investment advice.